155 related articles for article (PubMed ID: 11754193)
1. Ventral polyradiculopathy with pediatric acute lymphocytic leukemia.
Anderson SC; Baquis GD; Jackson A; Monteleone P; Kirkwood JR
Muscle Nerve; 2002 Jan; 25(1):106-10. PubMed ID: 11754193
[TBL] [Abstract][Full Text] [Related]
2. Anterior lumbosacral polyradiculopathy after intrathecal administration of methotrexate.
Pascual AM; Coret F; Casanova B; Láinez MJ
J Neurol Sci; 2008 Apr; 267(1-2):158-61. PubMed ID: 17949753
[TBL] [Abstract][Full Text] [Related]
3. Pure motor lumbosacral radiculopathy after intrathecal chemotherapy.
Santos-García D; Pardo J; Vázquez F; Rabuñal-Martínez MJ; Martín-Vigo AI; de la Fuente-Fernández R
Eur J Neurol; 2008 Aug; 15(8):e86-7. PubMed ID: 18549396
[No Abstract] [Full Text] [Related]
4. Lumbosacral polyradiculopathy after intrathecal chemotherapy in pediatric acute lymphoblastic leukemia.
Suematsu M; Imamura T; Chiyonobu T; Osone S; Hosoi H
Int J Hematol; 2018 May; 107(5):499-501. PubMed ID: 29470812
[No Abstract] [Full Text] [Related]
5. Re: Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.
Chamberlain MC; Glantz MJ
Blood; 2007 Sep; 110(5):1698; author reply 1698-9. PubMed ID: 17712051
[No Abstract] [Full Text] [Related]
6. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
Counsel P; Khangure M
Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
[No Abstract] [Full Text] [Related]
7. Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.
Kadan-Lottick NS; Brouwers P; Breiger D; Kaleita T; Dziura J; Northrup V; Chen L; Nicoletti M; Bostrom B; Stork L; Neglia JP
J Clin Oncol; 2009 Dec; 27(35):5986-92. PubMed ID: 19884541
[TBL] [Abstract][Full Text] [Related]
8. [Spinal subacute combined degeneration after intrathecal chemotherapy. Report of two cases].
Cartier R L; Parra V J; Puga B; Cardemil D
Rev Med Chil; 2018 Jun; 146(6):802-807. PubMed ID: 30148913
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials.
Vainionpää L; Kovala T; Tolonen U; Lanning M
Med Pediatr Oncol; 1997 Jan; 28(1):41-7. PubMed ID: 8950335
[TBL] [Abstract][Full Text] [Related]
10. Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.
Jabbour E; O'Brien S; Kantarjian H; Garcia-Manero G; Ferrajoli A; Ravandi F; Cabanillas M; Thomas DA
Blood; 2007 Apr; 109(8):3214-8. PubMed ID: 17209054
[TBL] [Abstract][Full Text] [Related]
11. Effective prevention of central nervous system leukemia with intrathecal methotrexate and intrathecal methotrexate, cytosine arabinoside, and hydrocortisone in childhood acute lymphocytic leukemia.
Aur RJ; Hanna M; Sabbah R; Sackey K; Willoughby S; Atwood J
Haematol Blood Transfus; 1990; 33():504-10. PubMed ID: 2323651
[No Abstract] [Full Text] [Related]
12. Myelopathy following intrathecal chemotherapy in adults: a single institution experience.
Cachia D; Kamiya-Matsuoka C; Pinnix CC; Chi L; Kantarjian HM; Cortes JE; Daver N; Woodman K
J Neurooncol; 2015 Apr; 122(2):391-8. PubMed ID: 25666482
[TBL] [Abstract][Full Text] [Related]
13. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
Moser AM; Adamson PC; Gillespie AJ; Poplack DG; Balis FM
Cancer; 1999 Jan; 85(2):511-6. PubMed ID: 10023723
[TBL] [Abstract][Full Text] [Related]
14. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia.
von der Weid NX; de Crousaz H; Beck D; Deonna T; Miklossy J; Janzer RC
Med Pediatr Oncol; 1991; 19(3):192-8. PubMed ID: 2023567
[TBL] [Abstract][Full Text] [Related]
15. Spinal Cord Toxicity from Intrathecal Chemotherapy: A Case with Clinicopathologic Correlation.
Dornbos D; Elder JB; Otero JJ; Baiocchi RA; Slone HW; Puduvalli VK; Giglio P
World Neurosurg; 2019 Aug; 128():381-384. PubMed ID: 31128312
[TBL] [Abstract][Full Text] [Related]
16. Cytarabine induced noncardiogenic pulmonary edema in a case of acute lymphoblastic leukemia.
Yegin ZA; Aki S; Sucak G; Yagci M
Int J Lab Hematol; 2007 Dec; 29(6):482-3. PubMed ID: 17988309
[No Abstract] [Full Text] [Related]
17. Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol.
Montour-Proulx I; Kuehn SM; Keene DL; Barrowman NJ; Hsu E; Matzinger MA; Dunlap H; Halton JM
J Child Neurol; 2005 Feb; 20(2):129-33. PubMed ID: 15794179
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron.
Holdsworth MT; Raisch DW; Winter SS; Chavez CM
Support Care Cancer; 1998 Mar; 6(2):132-8. PubMed ID: 9540172
[TBL] [Abstract][Full Text] [Related]
19. [Intrathecal chemotherapy in acute lymphoblastic leukemia. Prospective evaluation of toxicity using a combination employed in Mexico].
Gómez-Almaguer D; Almaguer-Gaona C; Mora-Brondo P; González-Llano O; Marfil-Rivera J; Villarreal G
Rev Invest Clin; 1988; 40(2):129-33. PubMed ID: 3175366
[No Abstract] [Full Text] [Related]
20. Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols.
Lo Nigro L; Di Cataldo A; Schiliro G
Med Pediatr Oncol; 2000 Nov; 35(5):449-55. PubMed ID: 11070476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
